Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.

Cancer Drug Spending Hits $100 Billion

May 6th 2015

Earlier diagnosis, longer treatment durations, and increased effectiveness of treatments helped to boost spending on cancer medicines to the $100 billion threshold in 2014, a rise of 10.3% for the year, and up markedly from $75 billion five years earlier.

More Effort Needed to Understand Value Breadth of Molecular Testing

May 6th 2015

As the use of testing increases, so does the importance of understanding exactly what it can do for your patients and how to get the most out of the results.

Votes Are Cast for OncLive's Giants of Cancer Care Awards from Among the Biggest Names in Cancer. Who Will Be the Winners?

April 30th 2015

Deliberations are complete and final votes cast for the winners of the 2015 Giants of Cancer Care Award recognizing individuals who have achieved landmark success in the field of oncology.

FDA Panels Support Approval of T-VEC in Melanoma

April 29th 2015

In a combined decision, members of the FDA's Oncologic Drugs Advisory Committee and Cellular, Tissue and Gene Therapies Advisory Committee voted 22-1 to recommend approval of the oncolytic immunotherapy talimogene laherparepvec (T-VEC) as a treatment for patients with advanced melanoma.

Dr. Alan Miller on Benefits of Liquid Biopsy

April 29th 2015

Alan M. Miller, MD, PhD, Director of the Baylor Charles A. Sammons Cancer Center and Chief of Oncology for the Baylor Health Care System discusses the benefits of liquid biopsy.

Improving Treatment Requires Collaboration and Transparency

April 26th 2015

Application of Payment Reform Models in Oncology

April 26th 2015

Practical Application and Utility of EMRs

April 26th 2015

Coverage Decisions for Off-Label Treatments

April 26th 2015

Cost Containment's Impact on Oncology Practices

April 26th 2015

Assessing the Cost of Cancer Care

April 26th 2015

Bundled Payments in Community Oncology

April 26th 2015

Moving Away From Traditional Payment Models in Oncology

April 26th 2015

Addressing Cancer Health Disparities

April 26th 2015

Reining in the Cost of Cancer Care

April 26th 2015

Reimbursement for Oncology Treatment

April 26th 2015

Bundled Payment Models for Cancer-Related Costs

April 26th 2015

US Cancer-Related Healthcare Costs on the Rise

April 26th 2015

Mission to Treat Rural Poor Is Challenged by Merger Pressure

April 26th 2015

For Gladys Rodriguez, MD, a practicing oncologist for 24 years, the daily schedule is filled with calls to payers and hours spent at the computer typing up electronic health records.

FDA Approves Second-Line Ramucirumab for mCRC

April 24th 2015

The FDA has approved second-line ramucirumab in combination with FOLFIRI as a treatment for patients with metastatic colorectal cancer (mCRC) following progression an upfront bevacizumab-containing regimen.